North America biotechnology market to reach $2.17tn by 2035

12 articles · Updated · BioSpace · May 4

The market was valued at $710.93bn in 2025 and is forecast to rise to $794.81bn in 2026, with the US holding the largest share and Canada expected to grow fastest.
Monoclonal antibodies and biologics led with a 30% technology share in 2025, while gene therapy and gene editing, diagnostics, CROs and CMOs, and bioinformatics services are projected to expand fastest.
The report links growth to precision medicine, genomics, AI, digital transformation and investment, despite regulatory uncertainty, funding pressures, supply-chain disruption and rising clinical-trial costs.

As biotech booms, will its multi-million dollar cures be accessible to the average person?

With AI designing drugs in minutes, can physical labs and clinical trials ever hope to keep up?

Can we trust a 'black box' AI to create our medicine if its reasoning remains a mystery?